Cleveland-Cliffs Explores Rare Earths After Beating Q3 Targets
Steel maker Cleveland-Cliffs beats Q3 earnings expectations and reveals rare-earth exploration plans at Michigan and Minnesota mines to reduce China dependence.
NOTRELOAD AI
Citi Bullish on Kodiak AI: First Mover in Autonomous Trucking
Citi gives Kodiak AI a Buy rating with $13.50 target. The autonomous trucking company is the first to earn commercial revenue from driverless trucks in the Permian Basin.
Ideaya Biosciences Stock Jumps on Promising Eye Cancer Treatment Results
Ideaya Biosciences shares rise after reporting breakthrough survival data for rare eye cancer treatment combining darovasertib with Pfizer's Xalkori in clinical trial.
Canaccord Launches Tempus AI Coverage with $110 Price Target
Canaccord initiates Tempus AI with Buy rating and $110 target, citing strong growth potential from AI-powered oncology testing and genomic profiling services.
iPhone 17 Launch Exceeds Expectations with 14% Sales Surge
Apple's iPhone 17 outsells iPhone 16 by 14% in first 10 days despite no AI upgrades. Strong demand in China for base model, US consumers favor Pro Max with carrier deals.
Galleri Blood Test Detects 7X More Cancers | GRAIL PATHFINDER 2 Results
GRAIL's Galleri blood test increases cancer detection by over 7-fold when added to routine screenings, catching more than 50 cancer types early when most treatable. PATHFINDER 2 study shows breakthrough results.